Sensei Biotherapeutics, a clinical-stage cancer immunotherapy company that opened a Boston R&D hub last year, has attracted high-profile investors for its Series B round. The actress Uma Thurman added to the biotech’s coffers, Bloomberg reported Tuesday, helping bring the financing round to $30 million.

The round was co-led by Apeiron Investment Group and Catalio Capital Management. Sensei also brought on new investors Pura Vida Investments and several international family offices, as well as existing…

Boston Biz Journal https://www.bizjournals.com/boston/inno/stories/fundings/2021/01/13/uma-therman-invests-sensei-biotherapeutics.html?ana=RSS&s=article_search